Showing results (141-150 of 151) with videos related to
Sort By:
Pageof 16
Leukemia|April 18, 2002
Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon alpha-2b for the treatment of chronic myelogenous leukemia patients in chronic phaseF Maloisel, A Guerci, D Guyotat, et al.Blood|January 11, 2000
Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow TransplantationP Guardiola, R Pasquini, I Dokal, et al.Bone Marrow Transplantation|January 10, 2017
Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular TherapyJ Gauthier, L Castagna, F Garnier, et al.Leukemia|July 13, 2007
Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trialsP Moreau, M Attal, F Garban, et al.Bone Marrow Transplantation|June 27, 2017
Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and EurocordS Nguyen, A Achour, L Souchet, et al.Bone Marrow Transplantation|March 24, 2015
Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT)M Mohty, F Malard, M Abecassis, et al.British Journal of Haematology|February 26, 2000
Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Société Française de Greffe de moelle (SFGM)M Michallet, M L Tanguy, G Socié, et al.Bone Marrow Transplantation|December 13, 2016
Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow TransplantationM van Gelder, L C de Wreede, M Bornhäuser, et al.Bone Marrow Transplantation|May 17, 2016
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow TransplantationM Mohty, F Malard, M Abecassis, et al.Bone Marrow Transplantation|November 24, 2015
Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)A C Mamez, V Lévy, P Chevallier, et al.Pageof 16